Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Das Thema chronische Unterbauch- und Viszeralschmerzen wird im Live-Webinar am 7. Mai von 17.30 bis 19 Uhr aus internistischer, gynäkologischer und psychologisch-neurowissenschaftlicher Perspektive beleuchtet. Besprochen werden krankheitsbedingte Ursachen, Mechanismen der kognitiven Schmerzmodulation sowie mögliche Therapieoptionen. Die Fortbildung ist mit 2 CME-Punkten zertifiziert. Melden Sie sich jetzt an!
Erweiterte Suche
Anmelden
nach oben
Journal of Genetic Counseling
Erschienen in: Journal of Genetic Counseling 4/2012

01.08.2012 | Review Paper

Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C): A Review of Molecular and Clinical Literature

verfasst von: Brittney Murray

Erschienen in: Journal of Genetic Counseling | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is heritable cardiomyopathy that may result in arrhythmia, heart failure, and sudden cardiac death (SCD). Approximately 50–60% of ARVD/C patient will have an identifiable pathogenic mutation in one of seven genes associated with the cardiac desmosome and other cardiac pathways. Genetic counseling remains complicated, however, because of great variable expressivity and reduced penetrance, even within members of the same family. Diagnosis of ARVD/C is made by meeting a set of major and minor diagnostic criteria, revised in 2010. Despite this, misdiagnosis is a chronic problem. Management of ARVD/C is aimed at reducing risk of sudden death/arrhythmias and preventing progression of disease. Strenuous physical activity is increasingly recognized as a significant risk factor in disease presentation and progression and is an important factor in preventative management. Anticipation of the psychosocial implications of this disease is also an important aspect of patient management. This review presents an overview of the clinical diagnosis, management, as well as disease mechanism and genetics of this rare cardiomyopathy.
Literatur
Alcalai, R., Metzger, S., Rosenheck, S., Meiner, V., & Chajek-Shaul, T. (2003). A recessive mutation in desmoplakin causes arrhythmogenic right ventricular dysplasia, skin disorder, and woolly hair. Journal of the American College of Cardiology, 16(2), 319–327.CrossRef
Awad, M. M., Dalal, D., Cho, E., Amat-Alarcon, N., James, C., Tichnell, C., et al. (2006a). DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. American Journal of Human Genetics, 79(1), 136–142.CrossRefPubMed
Awad, M. M., Dalal, D., Tichnell, C., James, C., Tucker, A., Abraham, T., et al. (2006b). Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2. Human Mutation, 27(11), 1157.CrossRefPubMed
Awad, M. M., Calkins, H., & Judge, D. P. (2008). Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nature Clinical Practice. Cardiovascular Medicine, 5(5), 258–267.CrossRefPubMed
Basso, C., Thiene, G., Corrado, D., Angelini, A., Nava, A., & Valente, M. (1996). Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation, 94(5), 983–991.CrossRefPubMed
Basso, C., Czarnowska, E., Della Barbera, M., Bauce, B., Beffagna, G., Wlodarska, E. K., Pilichou, K., Ramondo, A., Lorenzon, A., Wozniek, O., Corrado, D., Daliento, L., Danieli, G. A., Valente, M., Nava, A., Thiene, G., & Rampazzo, A. (2006). Ultrastructural evidence of intercalated disc remodeling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. European Heart Journal, 27(15), 1847–1854.
Basso, C., Corrado, D., Marcus, F. I., Nava, A., & Thiene, G. (2009). Arrhythmogenic right ventricular cardiomyopathy. Lancet, 11(9671), 1289–1300.CrossRef
Basso, C., Bauce, B., Corrado, D., & Thiene, G. (2011). Pathophysiology of arrhythmogenic cardiomyopathy. Nature Reviews Cardiology, [Epub ahead of print].
Bauce, B., Basso, C., Rampazzo, A., Beffagna, G., Daliento, L., Frigo, G., et al. (2005). Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. European Heart Journal, 26(16), 1666–1675.CrossRefPubMed
Bauce, B., Daliento, L., Frigo, G., Russo, G., & Nava, A. (2006). Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 127(2), 186–189.CrossRefPubMed
Bauce, B., Frigo, G., Benini, G., Michieli, P., Basso, C., Folino, A. F., et al. (2010). Differences and similarities between arrhythmogenic right ventricular cardiomyopathy and athlete’s heart adaptations. British Journal of Sports Medicine, 44(2), 148–154.CrossRefPubMed
Beffagna, G., Occhi, G., Nava, A., Vitiello, L., Ditadi, A., Basso, C., et al. (2005). Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovascular Research, 65(2), 366–373.CrossRefPubMed
Bhonsale, A., James, C. A., Tichnell, C., Murray, B., Gagarin, D., Philips, B., et al. (2011). Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. Journal of the American College of Cardiology, 58(14), 1485–1496.CrossRefPubMed
Bierkamp, C., Mclaughlin, K. J., Schwarz, H., Huber, O., & Kemler, R. (1996). Embryonic heart and skin defects in mice lacking plakoglobin. Developmental Biology, 180(2), 780–785.CrossRefPubMed
Bomma, C., Rutberg, J., Tandri, H., Nasir, K., Roguin, A., Tichnell, C., et al. (2004). Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of Cardiovascular Electrophysiology, 15(3), 300–306.CrossRefPubMed
Bonné, S., van Hengel, J., & van Roy, F. (2000). Assignment of the plakophilin-2 gene (PKP2) and a plakophilin-2 pseudogene (PKP2P1) to human chromosome bands 12p11 and 12p13, respectively, by in situ hybridization. Cytogenetics and Cell Genetics, 88(3–4), 286–287.PubMed
Bostwich, J. M., & Sola, C. L. (2007). An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life. Psychiatric Clinics of North America, 30(4), 677–688.CrossRef
Burke, A. P., Farb, A., Tashko, G., & Virmani, R. (1998). Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? Circulation, 97(16), 1571–1580.CrossRefPubMed
Calabrese, F., Basso, C., Carturan, E., Valente, M., & Thiene, G. (2006). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses? Cardiovascular Pathology, 15(1), 11–17.CrossRefPubMed
Calkins, H. (2008). Arrhythmogenic right ventricular dysplasia. Transactions of the American Clinical and Climatological Association, 119, 273–286.PubMed
Charron, P., Arad, M., Arbustini, E., Basso, C., Bilinska, Z., Elliott, P., et al. (2010). Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal, 31(22), 2715–2726.CrossRefPubMed
Coonar, A. S., Protonotarios, N., Tsatsopoulou, A., Needham, E. W., Houlston, R. S., Cliff, S., et al. (1998). Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation, 97(20), 2049–2058.CrossRefPubMed
Corrado, D., & Thiene, G. (2006). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation, 113(13), 1634–1637.CrossRefPubMed
Corrado, D., Thiene, G., Nava, A., Rossi, L., & Pennelli, N. (1990). Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. American Journal of Medicine, 89, 588–596.CrossRefPubMed
Corrado, D., Basso, C., Thiene, G., McKenna, W. J., Davies, M. J., Fontaliran, F., et al. (1997). Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. Journal of the American College of Cardiology, 30(6), 1512–1520.CrossRefPubMed
Corrado, D., Basso, C., & Thiene, G. (2000). Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart, 83(5), 588–595.CrossRefPubMed
Corrado, D., Basso, C., Rizzoli, G., Schiavon, M., & Thiene, G. (2003a). Does sports activity enhance the risk of sudden death in adolescents and young adults? Journal of the American College of Cardiology, 42, 1959–1963.CrossRefPubMed
Corrado, D., Leoni, L., Link, M. S., Della, B. P., Gaita, F., Curnis, A., et al. (2003b). Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation, 108(25), 3084–3091.CrossRefPubMed
Corrado, D., Basso, C., Leoni, L., Tokajuk, B., Bauce, B., Frigo, G., et al. (2005). Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation, 111(23), 3042–3050.CrossRefPubMed
Corrado, D., Basso, C., & Thiene, G. (2009). Arrhythmogenic right ventricular cardiomyopathy: an update. Heart, 95(9), 766–773.CrossRefPubMed
Corrado, D., Calkins, H., Link, M. S., Leoni, L., Favale, S., Bevilacqua, M., et al. (2010). Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation, 122(12), 1144–1152.CrossRefPubMed
Corrado, D., Basso, C., Pilichou, K., & Thiene, G. (2011). Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart, 97(7), 530–539.CrossRefPubMed
Cox, M. G., van der Zwaag, P. A., van der Werf, C., van der Smagt, J. J., Noorman, M., Bhuiyan, Z. A., et al. (2011). Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study. Circulation, 123(23), 2690–2700.CrossRefPubMed
Dalal, D., Nasir, K., Bomma, C., Prakasa, K., Tandri, H., Piccini, J., et al. (2005). Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation, 112(25), 3823–3832.CrossRefPubMed
Dalal, D., Molin, L. H., Piccini, J., Tichnell, C., James, C., Bomma, C., et al. (2006). Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation, 113(13), 1641–1649.CrossRefPubMed
Djurdjinovic, L. (1998). Psychosocial counseling. In D. Baker, J. Schuette, & W. R. Uhlmann (Eds.), A guide to genetic counseling (pp. 127–170). Hoboken: Wiley-Liss.
Fabritz, L., Hoogendijk, M. G., Scicluna, B. P., van Amersfoorth, S. C., Fortmueller, L., Wolf, S., et al. (2011). Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. Journal of the American College of Cardiology, 57(6), 740–750.CrossRefPubMed
Frank, R., Fontaine, G., Vedel, J., Mialet, G., Sol, C., Guiraudon, G., et al. (1978). Electrocardiology of 4 cases of right ventricular dysplasia inducing arrhythmia. Archives des Maladies du Coeur et des Vaisseaux, 71(9), 963–972.PubMed
Fressart, V., Duthoit, G., Donal, E., Probst, V., Deharo, J. C., Chevalier, P., et al. (2010). Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace, 12(6), 861–868.CrossRefPubMed
Gallo, P., d’Amati, G., & Pelliccia, F. (1992). Pathologic evidence of extensive left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy. Hum Pathol, 23(8), 948–952.CrossRefPubMed
Garcia-Gras, E., Lombardi, R., Giocondo, M. J., Willerson, J. T., Schneider, M. D., Khoury, D. S., et al. (2006). Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. The Journal of Clinical Investigation, 116(7), 2012–2021.CrossRefPubMed
Gerull, B., Heuser, A., Wichter, T., Paul, M., Basson, C. T., McDermott, D. A., et al. (2004). Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nature Genetics, 36(11), 1162–1164.CrossRefPubMed
Hamid, M. S., Norman, M., Quraishi, A., Firoozi, S., Thaman, R., Gimeno, J. R., et al. (2002). Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. Journal of the American College of Cardiology, 40(8), 1445–1450.CrossRefPubMed
Heuser, A., Plovie, E. R., Ellinor, P. T., Grossmann, K. S., Shin, J. T., Wichter, T., et al. (2006). Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. American Journal of Human Genetics, 79(6), 1081–1088.CrossRefPubMed
Hodgkinson, K. A., Parfrey, P. S., Bassett, A. S., Kupprion, C., Drenckhahn, J., Norman, M. W., et al. (2005). The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrrhythmogenic right ventricular cardiomyopathy (ARVD5). Journal of the American College of Cardiology, 45(3), 400–408.CrossRefPubMed
James, C. A., Hadley, D. W., Holtzman, N. A., & Winkelstein, J. A. (2006). How does the mode of inheritance of a genetic condition influence families? A study of guilt, blame, stigma, and understanding of inheritance and reproductive risks in families with X-linked and autosomal recessive diseases. Genetics in Medicine, 8(4), 234–242.CrossRefPubMed
James, C. A., Tichnell, C., Murray, B., Daly, A., Sears, S., & Calkins, H. (2012). General and disease-specific psychosocial adjustment in arrhythmogenic right ventricular dysplasia/cardiomyopathy patients with implantable cardioverter defibrillators: a large cohort study. Circulation: Cardiovascular Genetics [in press].
Jonkman, M. F., Pasmooij, A. M., Pasmans, S. G., van den Berg, M. P., Ter Horst, H. J., Timmer, A., et al. (2005). Loss of desmoplakin tail causes lethal acantholytic epidermolysis bullosa. American Journal of Human Genetics, 77(4), 653–660.CrossRefPubMed
Kapplinger, J. D., Landstrom, A. P., Salisbury, B. A., Callis, T. E., Pollevick, G. D., Tester, D. J., et al. (2011). Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. Journal of the American College of Cardiology, 57(23), 2317–2327.CrossRefPubMed
Kirchhof, P., Fabritz, L., Zwiener, M., Witt, H., Schafers, M., Zellerhoff, S., et al. (2006). Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation, 114(17), 1799–1806.CrossRefPubMed
Li, D., Liu, Y., Maruyama, M., Zhu, W., Chen, H., Zhang, W., et al. (2011). Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy. Human Molecular Genetics, 20(23), 4582–4596.CrossRefPubMed
Lombardi, R., Dong, J., Rodriguez, G., Bell, A., Leung, T. K., & Schwartz, R. J. (2009). Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circulation Research, 104(9), 1076–1084.CrossRefPubMed
Mallat, Z., Tedgui, A., Fontaliran, F., Frank, R., Durigon, M., & Fontaine, G. (1996). Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. The New England Journal of Medicine, 335(16), 1190–1196.CrossRefPubMed
Marcus, F. I., Fontaine, G. H., Guiraudon, G., Frank, R., Laurenceau, J. L., Malergue, C., et al. (1982). Right ventricular dysplasia: a report of 24 adult cases. Circulation, 65(2), 384–398.CrossRefPubMed
Marcus, F. I., Zareba, W., Calkins, H., Towbin, J. A., Basso, C., Bluemke, D. A., et al. (2009). Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm, 6(7), 984–992.CrossRefPubMed
Marcus, F., Basso, C., Gear, K., & Sorrell, V. L. (2010a). Pitfalls in the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. American Journal of Cardiology, 105(7), 1036–1039.CrossRefPubMed
Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., et al. (2010b). Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. European Heart Journal, 31(7), 806–814.CrossRefPubMed
Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayés de Luna, A., Corrado, D., Crosson, J. E., et al. (2004). Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation, 109(22), 2807–2816.CrossRefPubMed
McKenna, W. J., Thiene, G., Nava, A., Fontaliran, F., Blomstrom-Lundqvist, C., Fontaine, G., et al. (1994). Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J, 71(3), 215–218.CrossRefPubMed
McKoy, G., Protonotarios, N., Crosby, A., Tsatsopoulou, A., Anastasakis, A., Coonar, A., et al. (2000). Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet, 355(9221), 2119–2124.CrossRefPubMed
Merner, N. D., Hodgkinson, K. A., Haywood, A. F., Connors, S., French, V. M., Drenckhahn, J. D., et al. (2008). Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. American Journal of Human Genetics, 82(4), 809–821.CrossRefPubMed
Nava, A., Thiene, G., & Canciani, B. (1988). Famililal occurrence of right ventricular dysplasia: a study involving nine families. Journal of the American College of Cardiology, 12, 1222–1228.CrossRefPubMed
Nava, A., Bauce, B., Basso, C., Muriago, M., Rampazzo, A., Villanova, C., et al. (2000). Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. Journal of the American College of Cardiology, 36(7), 2226–2233.CrossRefPubMed
Norgett, E. E., Hatsell, S. J., Carvajal-Huerta, L., Cabezas, J. C., Common, J., Purkis, P. E., et al. (2000). Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Human Molecular Genetics, 9(18), 2761–2766.CrossRefPubMed
Norgett, E. E., Lucke, T. W., Bowers, B., Munro, C. S., Leigh, I. M., Kelsell, D. P., et al. (2006). Early death from cardiomyopathy in a family with autosomal dominant striate palmoplantar keratoderma and woolly hair associated with a novel insertion mutation in desmoplakin. The Journal of Investigative Dermatology, 126(7), 1651–1654.CrossRefPubMed
Piccini, J. P., Dalal, D., Roguin, A., Bomma, C., Cheng, A., Prakasa, K., et al. (2005). Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm, 2(11), 1188–1194.CrossRefPubMed
Pilichou, K., Nava, A., Basso, C., Beffagna, G., Bauce, B., Lorenzon, A., et al. (2006). Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation, 113(9), 1171–1179.CrossRefPubMed
Pilichou, K., Remme, C. A., Basso, C., Campian, M. E., Rizzo, S., Barnett, P., et al. (2009). Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. The Journal of Experimental Medicine, 206(8), 1787–1802.CrossRefPubMed
Rampazzo, A., Nava, A., Erne, P., Eberhard, M., Vian, E., Slomp, P., et al. (1995). A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Human Molecular Genetics, 4(11), 2151–2154.CrossRefPubMed
Rampazzo, A., Nava, A., Malacrida, S., Beffagna, G., Bauce, B., Rossi, V., et al. (2002). Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. American Journal of Human Genetics, 71(5), 1200–1206.CrossRefPubMed
Richardson, P., McKenna, W., Bristow, M., Maisch, B., Mautner, B., O’Connell, J., et al. (1995). Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation, 93(5), 841–842.
Roguin, A., Bomma, C. S., Nasir, K., Tandri, H., Tichnell, C., James, C., et al. (2004). Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 43(10), 1843–1852.CrossRefPubMed
Sears, S. E., Todaro, J. F., Lewis, T. S., Sotile, W., & Conti, J. B. (1999). Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review. Clinical Cardiology, 22(7), 481–489.CrossRefPubMed
Sen-Chowdhry, S., Lowe, M. D., Sporton, S. C., & McKenna, W. J. (2004). Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. American Journal of Medicine, 117(9), 685–695.CrossRefPubMed
Sen-Chowdhry, S., Syrris, P., & McKenna, W. J. (2005a). Desmoplakin disease in arrhythmogenic right ventricular cardiomyopathy: early genotype-phenotype studies. European Heart Journal, 26(16), 1582–1584.CrossRefPubMed
Sen-Chowdhry, S., Syrris, P., & McKenna, W. J. (2005b). Genetics of right ventricular cardiomyopathy. Journal of Cardiovascular Electrophysiology, 16(8), 927–935.CrossRefPubMed
Sen-Chowdhry, S., Syrris, P., Ward, D., Asimaki, A., Sevdalis, E., & McKenna, W. J. (2007). Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation, 115(13), 1710–1720.CrossRefPubMed
Sen-Chowdhry, S., Syrris, P., Prasad, S. K., Hughes, S. E., Merrifield, R., Ward, D., et al. (2008). Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. Journal of the American College of Cardiology, 52(25), 2175–2187.CrossRefPubMed
Sen-Chowdhry, S., Morgan, R. D., Chambers, J. C., & McKenna, W. J. (2010a). Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annual Review of Medicine, 61, 233–253.CrossRefPubMed
Sen-Chowdhry, S., Syrris, P., Pantazis, A., Quarta, G., McKenna, W. J., & Chambers, J. C. (2010b). Mutational heterogeneity, modifier genes, and environmental influences contribute to phenotypic diversity of arrhythmogenic cardiomyopathy. Circulation. Cardiovascular Genetics, 3(4), 323–330.CrossRefPubMed
Syrris, P., Ward, D., Evans, A., Asimaki, A., Gandjbakhch, E., Sen-Chowdhry, S., et al. (2006). Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. American Journal of Human Genetics, 79(5), 978–984.CrossRefPubMed
Tabib, A., Loire, R., Chalabreysse, L., Meyronnet, D., Miras, A., Malicier, D., et al. (2003). Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation, 108(24), 3000–3005.CrossRefPubMed
Tan, H. L., Hofman, N., van Langen, I. M., van der Wal, A. C., & Wilde, A. A. (2005). Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation, 112(2), 207–213.CrossRefPubMed
Taylor, M., Graw, S., Sinagra, G., Barnes, C., Slavov, D., Brun, F., et al. (2011). Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation, 124(8), 876–885.CrossRefPubMed
Tedford, R., James, C., Judge, D., Tichnell, C., Murray, B., Bhonsale, A., et al. (2012). Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology [in press].
Thiene, G., Nava, A., Corrado, D., Rossi, L., & Pennelli, N. (1988). Right ventricular cardiomyopathy and sudden death in young people. The New England Journal of Medicine, 318, 129–133.CrossRefPubMed
Thiene, G., Corrado, D., Nava, A., Rossi, L., Poletti, A., Boffa, G. M., et al. (1991). Right ventricular cardiomyopathy: is there evidence of an inflammatory aetiology? European Heart Journal, 12(Suppl D), 22–25.PubMed
Tiso, N., Stephan, D. A., Nava, A., Bagattin, A., Devaney, J. M., Stanchi, F., et al. (2001). Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Human Molecular Genetics, 10(3), 189–194.CrossRefPubMed
Towbin, J. A. (2008). Arrhythmogenic right ventricular cardiomyopathy: a paradigm of overlapping disorders. Annals of Noninvasive Electrocardiology, 13(4), 325–326.CrossRefPubMed
Uzumcu, A., Norgett, E. E., Dindar, A., Uyguner, O., Nisli, K., et al. (2006). Loss of desmoplakin isoform I causes early onset cardiomyopathy and heart failure in a Naxos-like syndrome. Journal of Medical Genetics, 43(2), 5.CrossRef
Valente, M., Calabrese, F., Thiene, G., Angelini, A., Basso, C., Nava, A., et al. (1998). In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. American Journal of Pathology, 152(2), 479–484.PubMed
van Tintelen, J. P., Entius, M. M., Bhuiyan, Z. A., Jongbloed, R., Wiesfeld, A. C., Wilde, A. A., et al. (2006). Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation, 113(13), 1650–1658.CrossRefPubMed
van Tintelen, J. P., van Gelder, I. C., Asimaki, A., Suurmeijer, A. J., Wiesfeld, A. C., Jongbloed, J. D., et al. (2009). Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. Heart Rhythm, 6(11), 1574–1583.CrossRefPubMed
Weil, J. (2002). Genetic counselling in the era of genomic medicine—as we move towards personalised medicine, it becomes more important to help patients understand genetic tests and make complex decisions about their health. EMBO Reports, 3(7), 590–593.CrossRefPubMed
Whittock, N. V., Wan, H., Morley, S. M., Garzon, M. C., Kristal, L., Hyde, P., et al. (2002). Compound heterozygosity for non-sense and mis-sense mutations in desmoplakin underlies skin fragility/woolly hair syndrome. The Journal of Investigative Dermatology, 118(2), 232–238.CrossRefPubMed
Wichter, T., & Breithardt, G. (2005). Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making? Journal of the American College of Cardiology, 45(3), 409–411.CrossRefPubMed
Wichter, T., Borggrefe, M., Haverkamp, W., Chen, X., & Breithardt, G. (1992). Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation, 86(1), 29–37.CrossRefPubMed
Wichter, T., Paul, M., Wollmann, C., Acil, T., Gerdes, P., Ashraf, O., et al. (2004). Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation, 109(12), 1503–1508.CrossRefPubMed
Wichter, T., Paul, T. M., Eckardt, L., Gerdes, P., Kirchhof, P., Bocker, D., et al. (2005). Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD? Herz, 30(2), 91–101.CrossRefPubMed
Xu, T., Yang, Z., Vatta, M., Rampazzo, A., Beffagna, G., Pilichou, K., et al. (2010). Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. Journal of the American College of Cardiology, 55(6), 587–597.CrossRefPubMed
Yang, Z., Bowles, N. E., Scherer, S. E., Taylor, M. D., Kearney, D. L., Ge, S., et al. (2006). Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation Research, 99(6), 646–655.CrossRefPubMed
Metadaten
Titel
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C): A Review of Molecular and Clinical Literature
verfasst von
Brittney Murray
Publikationsdatum
01.08.2012
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 4/2012
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-012-9497-7

Weitere Artikel der Ausgabe 4/2012

Journal of Genetic Counseling 4/2012 Zur Ausgabe

Original Research

Giving and Withholding of Information following Genomic Screening: Challenges Identified in a Study of Primary Care Physicians in Estonia

Original Research

What Information Do Cancer Genetic Counselees Prioritize?

Original Research

Delivering a Pharmacogenetic Service: Is There a Role for Genetic Counselors?

Professional Issues

Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline

Original Research

Defining the Role of Laboratory Genetic Counselor

Original Research

Effects of a Documentary Film on Public Stigma Related to Mental Illness Among Genetic Counselors

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise